ZHEJIANG-DAHUA-TECH
10.5.2021 15:47:05 CEST | Business Wire | Press release
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, has recently released its upgraded WizMind series, offering a comprehensive project-oriented product portfolio and flexible AI solutions that focus on human, vehicle, object and thermal technology to empower vertical markets with enhanced AI experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210510005414/en/
Human-based Applications
Adopting topnotch AI chip and algorithms, the upgraded human-based WizMind solution includes privacy protection 2.0, face recognition 2.0, human video metadata 2.0 and other advanced AI performance to enable timely responses to incidents while providing accurate customer flow, crowd density, target direction, etc. to assist in further business analysis. Privacy Protection 2.0 offers additional occlusion options (irregular polygons, mosaics, and colored blocks) and supports code exporting based on specified targets, ensuring privacy safety of people and places.
Vehicle-based Applications
The upgraded vehicle-based WizMind solution integrates ANPR, parking space management, vehicle metadata 2.0 and other technologies to serve multiple vehicle-based scenes. It can accurately detect and display parking status and number of available parking spaces, and supports overlaying a variety of information on the vehicle’s snapshot. Moreover, a dual-PTZ system can even capture detailed images of vehicles under occlusion.
Object-based Applications
As a brand new feature of the upgraded WizMind, the Dahua object monitoring technology utilizes deep-learning algorithms to detect up to six kinds of objects. It can effectively filter out false alarms caused by interference and provide customers with accurate alarm information. Through the linkage alarm connected to the administrator, it can help passenger find missing items, or detect a blockage at the fire exit, thus reducing property loss and increasing safety level.
Thermal Imaging Applications
Dahua thermal imaging technology adopts the industry-leading thermal imaging sensor and excellent image processing algorithm to deliver 24/7 long-range surveillance performance. Its abnormal behavior detection, high-accurate alarms and other AI-enabled intelligent analysis functions make it ideal for airports, border security, infrastructures, fire prevention, etc.
WizMind Ecosystem
Dahua WizMind is compatible with a variety of third-party platforms. It provides sufficient API to allow integration with Dahua partners’ systems. Dahua DHOP supports third-party access to WizMind IPC and thermal cameras, enabling customization of flexible camera functions.
Boasting accurate, reliable and comprehensive AI-powered technical highlights, the upgraded WizMind series brings high-end customized solutions and convenience to users with project needs in traffic management, building, retail, energy and many other industries.
*Product launch date might vary depending on countries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005414/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
Unpack ’26 sommerrejsetrends: Flere vælger indenlandske rejser, når de tænker mere bevidst over deres rejsevalg21.5.2026 12:35:00 CEST | Pressemeddelelse
Rejsebranchens førende databrevne trendrapport lancerer sin første sommerudgave nogensinde – Unpack ’26 Summer: The Trends in Travel I dag har Hotels.com udgivet Unpack ’26 Summer: The Trends in Travel, den nyeste udgave af virksomhedens førende trendrapport i rejsebranchen, som viser, hvordan rejseadfærd former sommerens rejsevalg. Efterspørgslen på indenlandske rejser præger sommerens ferieplanlægning. Interessen på sociale medier for indenlandske ferier er globalt steget med 77% sammenlignet med sidste år, og 44% af danske rejsende planlægger en indenlandsk rejse denne sommer*. Fra store sportsbegivenheder og koncerter til rejser inspireret af film og tv bygger Unpack ’26 Summer på indsigter fra den årlige hovedrapport Unpack ’26: The Trends in Travel™ for at fremhæve, hvor rejsende tager hen denne sommer. HHver tendens bygger på førstehåndsdata fra Hotels.com® kombineret med indsigter fra rejsende og overvågning af sociale medier. “Denne sommer bliver der stadig rejst – men på nye
SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 12:30:00 CEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
